Maintaining Evidence-based Opioid Agonist Treatment During a Methadone to Buprenorphine Rotation With Slow-release Oral Morphine

Case study
by
Costa, Tianna et al

Release Date

2023

Geography

Canada

Language of Resource

English

Full Text Available

No

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

We present the case of a 34-year-old male presenting to the hospital with stimulant-induced psychosis, wishing to transition from methadone to buprenorphine.

Findings/Key points

This case highlights an approach to facilitate transitioning from methadone to buprenorphine-naloxone and subsequently buprenorphine extended-release injection that prioritizes patient comfort and treatment retention, maintaining the use of evidence-based opioid agonist therapy throughout treatment.

doi.org

Keywords

Transitions in care/treatment
Substitution/OAT